Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Escherichia coli

ABSTRACT: Antimicrobial-resistant bacteria in environments

PROVIDER: PRJDB13852 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	DRR391246_1.fastq.gz	Fastqsanger.gz
	DRR391246_2.fastq.gz	Fastqsanger.gz
	DRR391247_1.fastq.gz	Fastqsanger.gz
	DRR391247_2.fastq.gz	Fastqsanger.gz
	DRR397947_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 116

Similar Datasets

Escherichia coli

Project description:Genome sequence analysis of antimicrobial-resistant bacteria

| PRJDB8858 | ENA

Escherichia coli

Project description:Collateral sensitivity of antibiotic resistant bacteria to antimicrobial peptides

| PRJNA379428 | ENA

Escherichia coli

Project description:Large plasmid sequencing, antimicrobial resistant Escherichia coli strains

| PRJDB9410 | ENA

In vivo fitness of sul gene-dependent sulfonamide-resistant Escherichia coli in the mammalian gut

Project description:Sulfonamides are traditional synthetic antimicrobial agents used in clinical and veterinary medical settings. Their long-term excessive overuse has resulted in widespread microbial resistance, limiting their application for medical interventions. Resistance to sulfonamides is primarily conferred by the alternative genes sul1, sul2, and sul3 encoding dihydropteroate synthase in bacteria. Studying the potential fitness cost of these sul genes is crucial for understanding the evolution and transmission of sulfonamide-resistant bacteria. In vitro studies have been conducted on the fitness cost of sul genes in bacteria. In this study, we provide critical insights into bacterial adaptation and transmission using an in vivo approach.

2024-07-04 | PXD053633 |

Porin-mediated passage of negamycin across the outer membrane of Escherichia coli

Project description:The rise of antimicrobial resistant pathogens calls for new antibacterial treatments, but potent new compounds are scarce. Development of new antibiotics is difficult, especially against Gram-negative bacteria, as here uptake is strongly hindered by the additional outer membrane. Most antimicrobial agents against Gram-negatives use the porin mediated pathway to cross the outer membrane, which limits the choice of an antibiotic, as it has to fit by size, charge and hydrophilicity. In E. coli, the major porins OmpF and OmpC are associated with antibiotic translocation and therefore also with unspecific antibiotic cross-resistance. In this regard, alternative uptake routes are of interest. We were interested in the uptake opportunities of the small, natural product antibiotic negamycin and thereby found new uptake pathways across the outer membrane of E. coli. Besides OmpF and OmpC, we investigated the role of the minor porins OmpN and ChiP in negamycin translocation. We detected an effect of OmpN and ChiP on negamycin susceptibility and confirmed passage by electrophysiological assays. The structure of OmpN was resolved in order to analyze the negamycin translocation mechanism by computational simulations. As abundancy of these minor porins was low in E. coli, their transcript levels were analyzed by RNA-Seq. Increased transcripts levels of ompN and chiP were observed upon negamycin treatment, hinting at a role in antibiotic uptake. These new, additional uptake pathways across the outer membrane of E. coli highlight the antibiotic potential of negamycin, especially as resistance development is low due to availability of multiple uptake routes at both the outer and inner membranes

2023-10-01 | GSE183363 | GEO

Escherichia coli

Project description:Survey on antimicrobial resistance bacteria carried by Nara deer

| PRJDB17709 | ENA

Escherichia coli

Project description:whole genome and RNA sequencing of antimicrobial resistant Escherichia coli

| PRJDB17054 | ENA

Escherichia coli

Project description:Plasmid sequencing, antimicrobial resistant Escherichia coli from wild boar meats

| PRJDB16294 | ENA

Escherichia coli

Project description:Antimicrobial resistant Escherichia coli isolated from Irish commercial pig farms